close

Endologix, Inc. engages in the development, manufacture, marketing, and sale of minimally invasive therapies for the treatment of vascular diseases. It offers Powerlink System, a catheter and endoluminal graft for the treatment of abdominal aortic aneurysm, a weakening of the wall of the aorta, an artery of the body. The Powerlink System consists of a self-expanding cobalt chromium alloy stent cage covered with an ePTFE graft; and is implanted in the abdominal aorta that is accessed through the femoral artery. Its Powerlink System shunts away the blood flow from the weakened or aneurysmal section of the aorta, reducing pressure and potential for the aorta to rupture. The Powerlink System includes infrarenal bifurcated systems, and aortic cuffs and limb extensions; and IntuiTrak to deliver and deploy the Powerlink stent graft. It sells its products primarily in the United States, Europe, and Japan. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is based in Irvine, California.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	14.01
Volume	991152
Volume Avg	405834
52 Week High	13.79
52 Week Low	5.69
PE	N/A
PE (group average)	39
EPS Year	-0.51
EPS change Q/Q	1000%
EPS change Q/Q Yr ago	100%
EPS change Q/Q next Q est	-125%
EPS change Y/Y	1000%
REV change Q/Q	-3.65%
REV change Q/Q Yr ago	27.59%
EPS next Q est	-0.04
EPS next Y est	0.15
Divident Annual	0.00
Dividend Yield	0%